C-0021158

N/A

Report date: 2024/10/18 17:38:04

Base Information

Drug NameC-0021158
Drug Alias NameC-0021158
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionArginase 2 inhibitors
TargetsArginase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca TurkeyCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca TurkeyCancer Research UK
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A